Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.36 CHF | +5.00% | -0.30% | -2.33% |
15/03 | Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024 | |
15/03 | Molecular Partners Swings to Loss in FY23; Revenue Down | MT |
Sales 2024 * | 13.86M 15.16M 1.27B | Sales 2025 * | 18.66M 20.4M 1.7B | Capitalization | 110M 121M 10.08B |
---|---|---|---|---|---|
Net income 2024 * | -59M -64.51M -5.39B | Net income 2025 * | -61M -66.7M -5.57B | EV / Sales 2024 * | 7.97 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 5.92 x |
P/E ratio 2024 * |
-1.98
x | P/E ratio 2025 * |
-1.81
x | Employees | 168 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.11% |
Latest transcript on Molecular Partners AG
1 day | +5.00% | ||
1 week | -0.30% | ||
Current month | -8.57% | ||
1 month | -11.58% | ||
3 months | -16.00% | ||
6 months | +2.13% | ||
Current year | -2.33% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 52 | 23/04/23 | |
Patrick Amstutz
FOU | Founder | 49 | 23/04/23 |
Michael Pitzner
CMP | Compliance Officer | - | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Burns
CHM | Chairman | 76 | 31/17/31 |
Steven Holtzman
BRD | Director/Board Member | 70 | 19/14/19 |
Vito Palombella
BRD | Director/Board Member | 61 | 01/20/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 3.36 | +5.00% | 3,521 |
25/24/25 | 3.2 | -1.84% | 20,118 |
24/24/24 | 3.26 | -4.54% | 3,428 |
23/24/23 | 3.415 | +3.48% | 3,527 |
22/24/22 | 3.3 | -2.08% | 355 |
Delayed Quote Swiss Exchange, April 26, 2024 at 09:01 pm IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.33% | 121M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MOLN Stock